Tag Archives: aes-103

Update on clinical trials in sickle cell disease

MST-188 Otherwise known as Purified Poloxamer 188, is a designated orphan drug by the US Food and Drug Administration (FDA) for trial in sickle cell disease. It is a synthetic co-polymer of polyoxyethylene (POE) and polyoxypropylene (POP) and is thought … Continue reading

Posted in drug trials, sickle cell disease | Tagged , , , , , , , | Leave a comment